Post-treatment evaluations showed that the immunotherapy eliminated 95% of pre-cancerous spots on subjects' faces.

A paper published in the Journal of Clinical Oncology, titled "Comparative Analysis of Intracranial Response Assessment ...

Song Park, MD, University of Washington Medicine, advocates for more user-friendly technology to support equitable skin cancer care access.

Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first ...

When did you last have a skin check for skin cancer? If you can’t remember, then it was probably too long ago.

Nov. 19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor ...

Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...